Prognostic Stage IV Breast Cancer AJCC v8 Withdrawn Phase 2 Trials for Abemaciclib (DB12001)

IndicationStatusPhase
DBCOND0109667 (Prognostic Stage IV Breast Cancer AJCC v8)Withdrawn2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04351230T-DM1 With or Without Abemaciclib for the Treatment of HER2-Positive Metastatic Breast CancerTreatment